Vasoactive agents are commonly required in the management of septic shock n
ot only to restore a sufficient tissue perfusion pressure but also to incre
ase blood flow and oxygen delivery to the organs. Importantly, vasoactive a
gents are no substitute for fluid therapy. Defining end points for therapy
remains difficult. These should be, above all, clinical. Even though the gu
t may play an important role in the development of multiple organ failure,
the use of gastric tonometry to guide therapy cannot be recommended at this
time. Study of the microcirculation at the bedside with orthogonal polariz
ation spectral imaging may be helpful in the future. Adrenergic agents are
the preferred agents for hemodynamic stabilization. Dopamine and norepineph
rine are the drugs of choice to increase arterial pressure. Dobutamine rema
ins the agent of choice to increase blood flow to the organs, including the
gut and the kidneys. Many questions remain unanswered with respect to opti
mal hemodynamic management of septic shock.